| |
| |
|
| Insider
Information: |
Robichaud Albert |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
145,553 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
145,553 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sage Therapeutics, Inc. |
SAGE |
|
2023-02-03 |
145,553 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-02-03 |
4 |
D |
$44.16 |
$49,768 |
D/D |
(1,127) |
145,553 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,375 |
146,680 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-10-19 |
4 |
D |
$40.29 |
$44,964 |
D/D |
(1,116) |
142,619 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
143,735 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
140,795 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-06-15 |
4 |
D |
$58.80 |
$67,267 |
D/D |
(1,144) |
139,651 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2019-12-09 |
4 |
B |
$64.16 |
$1,604,000 |
D/D |
25,000 |
136,400 |
0.01 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2019-12-09 |
4 |
OE |
$1.36 |
$316,746 |
D/D |
15,743 |
111,400 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2019-07-25 |
4 |
D |
$161.38 |
$88,436 |
D/D |
(548) |
95,657 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2019-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,900 |
96,205 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2019-01-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
825 |
94,137 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2017-12-14 |
4 |
AS |
$156.31 |
$9,565,957 |
D/D |
(60,000) |
94,259 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2016-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
154,259 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2016-12-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
154,759 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2016-12-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
250 |
155,259 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2016-10-28 |
4 |
OE |
$1.36 |
$20,790 |
D/D |
15,287 |
155,509 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2016-07-12 |
4 |
AS |
$40.00 |
$880,000 |
D/D |
(22,000) |
140,222 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2016-01-25 |
4 |
AS |
$40.02 |
$800,400 |
D/D |
(20,000) |
162,222 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2015-08-03 |
4 |
AS |
$67.06 |
$804,720 |
D/D |
(12,000) |
182,222 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2015-07-01 |
4 |
AS |
$70.62 |
$1,154,157 |
D/D |
(16,000) |
194,222 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2015-06-01 |
4 |
AS |
$71.21 |
$1,164,735 |
D/D |
(16,000) |
210,222 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2014-07-23 |
4 |
B |
$18.00 |
$72,000 |
D/D |
4,000 |
226,222 |
2.74 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Chief Scientific OfficerOffice |
• – – |
2014-07-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
222,222 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
